查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566092

下肢靜脈瘤治療市場:全球產業分析，規模，佔有率，成長，趨勢，預測，2024～2031年

Varicose Veins Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 174 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於靜脈曲張治療市場的綜合報告。該報告全面評估了主要市場動態，包括市場推動因素、趨勢、機會和課題，並提供了有關市場結構的詳細見解。本研究報告提供了獨家數據和統計數據，概述了 2024 年至 2031 年靜脈曲張治療市場的預期成長軌跡。

主要的洞察

  • 靜脈曲張治療市場規模（2024 年）：8.286 億美元
  • 預估市場規模（2031 年）：13.221 億美元
  • 全球市場成長率（2024 年至 2031 年複合年增長率）：6.9%

靜脈曲張治療市場 - 報告範圍：

靜脈曲張是腫脹、扭曲的靜脈，通常是藍色或深紫色，是由腿部瓣膜和靜脈衰弱引起的。治療方法包括改變生活方式、壓力襪、硬化療法、雷射療法、靜脈熱消融術和手術幹預。這個市場主要是由於人口老化、久坐的生活方式和肥胖率上升而導致靜脈曲張盛行率不斷上升。此外，治療技術的進步和對靜脈曲張治療方案認識的提高預計將推動市場成長。

市場推動因素：

靜脈曲張治療市場是由幾個關鍵因素推動的，包括人口老化的加劇，他們更容易患血管疾病。肥胖和相關健康問題的發生率不斷增加，加上久坐的生活方式，進一步推動了對有效靜脈曲張治療的需求不斷增長。雷射消融和射頻消融等微創治療的技術進步正在改善患者的治療效果並提高採用率。此外，人們對靜脈曲張治療相關美容手術的認識和接受度不斷提高預計將推動市場成長。

市場阻礙因素：

儘管預計將顯示出有希望的成長，但靜脈曲張治療市場面臨著與先進治療選擇的高成本相關的課題，這可能限制了一些患者的獲得，特別是在新興市場。此外，缺乏對治療方案和相關風險的認識可能會阻礙市場成長。有關批准新治療技術的監管課題也會減緩創新解決方案的推出。

市場機會：

在醫療保健支出增加和注重改善患者治療結果的推動下，靜脈曲張治療市場呈現出巨大的成長機會。治療技術的創新，例如非侵入性技術和改進的手術技術，有望提高靜脈曲張治療的有效性和安全性。預防性醫療保健和生活方式改善的日益增長的趨勢為市場參與者提供了製定全面治療和管理計劃的機會。此外，醫療保健提供者和技術公司之間加強合作可能會加速先進治療方法的開發。

本報告涵蓋的主要問題

  • 推動靜脈曲張治療市場全球成長的關鍵因素是什麼？
  • 每個地區最需要哪些治療方法？
  • 由於技術進步，靜脈曲張治療市場的競爭格局發生了什麼樣的變化？
  • 誰是靜脈曲張治療市場的主要公司？
  • 全球靜脈曲張治療市場的新趨勢和未來前景是什麼？

目錄

第1章 摘要整理

第2章 市場概要

  • 市場範圍和定義
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
    • 主要趨勢
  • 宏觀經濟要素
    • 全球各部門展望
    • 全球GDP成長展望
    • 全球醫療費用支出展望
  • COVID-19影響分析
  • 預測要素-相關性及影響

第3章 附加價值的洞察

  • 產品採用分析
  • 疾病流行病學
  • 法規情形
  • 價值鏈分析
  • 大環境分析
  • 波特的五力分析
  • 由於主要加入企業的推銷策略

第4章 全球下肢靜脈瘤治療市場展望:實際成果(2019～2023年)與預測(2024～2031年)

    • 市場規模(100萬美元)和與前一年同期比較成長率
    • 絕對金額機會
  • 市場規模(100萬美元)分析與預測
    • 過去的市場規模(100萬美元)分析，2019～2023年
    • 目前市場規模(100萬美元)的分析與預測，2024～2031年
  • 全球下肢靜脈瘤治療市場展望:治療
    • 簡介/主要調查結果
    • 過去的市場規模(100萬美元)分析，不同治療，2019～2023年
    • 目前市場規模(100萬美元)分析與預測，不同治療，2024～2031年
      • 靜脈消融
      • 硬化療法
      • 手術結紮
    • 市場魅力分析:治療
  • 全球下肢靜脈瘤治療市場展望:終端用戶
    • 簡介/主要調查結果
    • 過去的市場規模(100萬美元)分析，各終端用戶，2019～2023年
    • 目前市場規模(100萬美元)的分析與預測，各終端用戶，2024～2031年
      • 靜脈診所
      • 醫院
      • 門診病人診療單位
    • 市場魅力分析:終端用戶

第5章 全球下肢靜脈瘤治療市場展望:各地區

  • 2019～2023年的各地區市場規模(100萬美元)的過去分析
  • 目前市場規模(100萬美元)分析與預測，各地區，2024～2031年
    • 北美
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 南美
    • 中東·非洲
  • 市場魅力分析:地區

第6章 北美的下肢靜脈瘤治療市場展望:實際成果(2019～2023年)與預測(2024～2031年)

第7章 歐洲的下肢靜脈瘤治療市場展望:實際成果(2019～2023年)與預測(2024～2031年)

第8章 東亞的下肢靜脈瘤治療市場展望:實際成果(2019～2023年)與預測(2024～2031年)

第9章 南亞和大洋洲的下肢靜脈瘤治療市場展望:實際成果(2019～2023年)與預測(2024～2031年)

第10章 南美的下肢靜脈瘤治療市場展望:實際成果(2019～2023年)與預測(2024～2031年)

第11章 中東·非洲的下肢靜脈瘤治療市場展望:實際成果(2019～2023年)與預測(2024～2031年)

第12章 競爭情形

  • 市場佔有率分析，2024年
  • 市場結構
    • 各市場的競爭強度圖
    • 競爭儀表板
  • 企業簡介(詳細內容-概要，財務，策略，最近的趨勢)
    • Angio Dynamics
    • Medtronic
    • Teleflex Incorporated
    • Sciton, Inc.
    • Dornier Medtech
    • Merit Medical Systems
    • Alma Lasers
    • Biolitec AG
    • Boston Scientific Corporation

第13章 附錄

  • 調查手法
  • 調查的前提
  • 縮寫和簡稱
簡介目錄
Product Code: PMRREP34797

Persistence Market Research has recently released a comprehensive report on the Varicose Veins Treatment Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the Varicose Veins Treatment Market from 2024 to 2031.

Key Insights:

  • Varicose Veins Treatment Market Size (2024E): USD828.6 Million
  • Projected Market Value (2031F): USD1322.1 Million
  • Global Market Growth Rate (CAGR 2024 to 2031): 6.9%

Varicose Veins Treatment Market - Report Scope:

Varicose veins are swollen, twisted veins that often appear blue or dark purple and are caused by weakened valves and veins in the legs. The treatment options include lifestyle changes, compression stockings, sclerotherapy, laser therapy, endovenous thermal ablation, and surgical interventions. The market is primarily driven by the increasing prevalence of varicose veins due to aging populations, sedentary lifestyles, and rising obesity rates. Moreover, advancements in treatment technologies and increased awareness of varicose vein treatment options are expected to propel market growth.

Market Growth Drivers:

The Varicose Veins Treatment Market is propelled by several key factors, including a growing aging population that is more susceptible to vascular disorders. The increasing incidence of obesity and related health issues, coupled with sedentary lifestyles, further contributes to the rising demand for effective varicose veins treatments. Technological advancements in minimally invasive treatment options, such as laser ablation and radiofrequency ablation, are enhancing patient outcomes and driving adoption rates. Additionally, increased awareness and acceptance of cosmetic procedures related to varicose vein treatments are expected to boost market growth.

Market Restraints:

Despite promising growth prospects, the Varicose Veins Treatment Market faces challenges related to the high costs of advanced treatment options, which may limit accessibility for some patients, especially in developing regions. Additionally, the lack of awareness about treatment options and associated risks can hinder market growth. Regulatory challenges regarding the approval of new treatment technologies may also slow down the introduction of innovative solutions.

Market Opportunities:

The Varicose Veins Treatment Market presents significant growth opportunities driven by rising healthcare expenditures and a focus on improving patient outcomes. Innovations in treatment technologies, such as non-invasive procedures and improved surgical techniques, are expected to enhance the efficacy and safety of varicose vein treatments. The growing trend towards preventive healthcare and lifestyle modifications offers opportunities for market players to develop comprehensive treatment and management plans. Furthermore, increasing collaboration between healthcare providers and technology companies can facilitate the development of advanced treatment modalities.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Varicose Veins Treatment Market globally?
  • Which treatment modalities are experiencing the highest demand across different regions?
  • How are technological advancements reshaping the competitive landscape of the Varicose Veins Treatment Market?
  • Who are the key players contributing to the Varicose Veins Treatment Market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global Varicose Veins Treatment Market?

Competitive Intelligence and Business Strategy:

Leading players in the Varicose Veins Treatment Market, including Medtronic plc, Boston Scientific Corporation, and AngioDynamics, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced treatment solutions, including minimally invasive techniques and improved sclerotherapy agents. Collaborations with healthcare providers, clinical research organizations, and regulatory agencies facilitate market access and promote technology adoption. Additionally, an emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving landscape of varicose veins treatment.

Key Companies Profiled:

  • Angio Dynamics
  • Medtronic
  • Teleflex Incorporated
  • Sciton, Inc.
  • Dornier Medtech
  • Merit Medical Systems
  • Alma Lasers
  • Biolitec AG
  • Boston Scientific Corporation

Varicose Veins Treatment Market Segmentation

By Treatment

  • Endovenous Ablation
  • Sclerotherapy
  • Surgical Ligation

By End User

  • Vein Clinics
  • Hospitals
  • Ambulatory Care Unit

By Region

  • North America
  • Latin America
  • Europe
  • South Asia & Oceania
  • East Asia
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Varicose Veins Treatment Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
    • 2.3.3. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Disease Epidemiology
  • 3.3. Regulatory Landscape
  • 3.4. Value Chain Analysis
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis
  • 3.7. Promotional Strategies, By Key Players

4. Global Varicose Veins Treatment Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2023
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2024-2031
  • 4.3. Global Varicose Veins Treatment Market Outlook: Treatment
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Mn) Analysis, By Treatment, 2019-2023
    • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2024-2031
      • 4.3.3.1. Endovenous Ablation
      • 4.3.3.2. Sclerotherapy
      • 4.3.3.3. Surgical Ligation
    • 4.3.4. Market Attractiveness Analysis: Treatment
  • 4.4. Global Varicose Veins Treatment Market Outlook: End User
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
    • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
      • 4.4.3.1. Vein Clinics
      • 4.4.3.2. Hospitals
      • 4.4.3.3. Ambulatory Care Unit
    • 4.4.4. Market Attractiveness Analysis: End User

5. Global Varicose Veins Treatment Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
  • 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024-2031
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Varicose Veins Treatment Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 6.2.1. By Country
    • 6.2.2. By Treatment
    • 6.2.3. By End User
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2024-2031
    • 6.4.1. Endovenous Ablation
    • 6.4.2. Sclerotherapy
    • 6.4.3. Surgical Ligation
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 6.5.1. Vein Clinics
    • 6.5.2. Hospitals
    • 6.5.3. Ambulatory Care Unit
  • 6.6. Market Attractiveness Analysis

7. Europe Varicose Veins Treatment Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 7.2.1. By Country
    • 7.2.2. By Treatment
    • 7.2.3. By End User
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkiye
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2024-2031
    • 7.4.1. Endovenous Ablation
    • 7.4.2. Sclerotherapy
    • 7.4.3. Surgical Ligation
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 7.5.1. Vein Clinics
    • 7.5.2. Hospitals
    • 7.5.3. Ambulatory Care Unit
  • 7.6. Market Attractiveness Analysis

8. East Asia Varicose Veins Treatment Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 8.2.1. By Country
    • 8.2.2. By Treatment
    • 8.2.3. By End User
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2024-2031
    • 8.4.1. Endovenous Ablation
    • 8.4.2. Sclerotherapy
    • 8.4.3. Surgical Ligation
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 8.5.1. Vein Clinics
    • 8.5.2. Hospitals
    • 8.5.3. Ambulatory Care Unit
  • 8.6. Market Attractiveness Analysis

9. South Asia & Oceania Varicose Veins Treatment Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 9.2.1. By Country
    • 9.2.2. By Treatment
    • 9.2.3. By End User
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2024-2031
    • 9.4.1. Endovenous Ablation
    • 9.4.2. Sclerotherapy
    • 9.4.3. Surgical Ligation
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 9.5.1. Vein Clinics
    • 9.5.2. Hospitals
    • 9.5.3. Ambulatory Care Unit
  • 9.6. Market Attractiveness Analysis

10. Latin America Varicose Veins Treatment Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 10.2.1. By Country
    • 10.2.2. By Treatment
    • 10.2.3. By End User
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2024-2031
    • 10.4.1. Endovenous Ablation
    • 10.4.2. Sclerotherapy
    • 10.4.3. Surgical Ligation
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 10.5.1. Vein Clinics
    • 10.5.2. Hospitals
    • 10.5.3. Ambulatory Care Unit
  • 10.6. Market Attractiveness Analysis

11. Middle East & Africa Varicose Veins Treatment Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 11.2.1. By Country
    • 11.2.2. By Treatment
    • 11.2.3. By End User
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment, 2024-2031
    • 11.4.1. Endovenous Ablation
    • 11.4.2. Sclerotherapy
    • 11.4.3. Surgical Ligation
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 11.5.1. Vein Clinics
    • 11.5.2. Hospitals
    • 11.5.3. Ambulatory Care Unit
  • 11.6. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Angio Dynamics
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Medtronic
    • 12.3.3. Teleflex Incorporated
    • 12.3.4. Sciton, Inc.
    • 12.3.5. Dornier Medtech
    • 12.3.6. Merit Medical Systems
    • 12.3.7. Alma Lasers
    • 12.3.8. Biolitec AG
    • 12.3.9. Boston Scientific Corporation

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations